Evoke Pharma Share Holder Equity 2012-2024 | EVOK
Evoke Pharma share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Evoke Pharma Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$-3 |
| 2022 |
$4 |
| 2021 |
$4 |
| 2020 |
$-3 |
| 2019 |
$4 |
| 2018 |
$4 |
| 2017 |
$2 |
| 2016 |
$4 |
| 2015 |
$3 |
| 2014 |
$9 |
| 2013 |
$21 |
| 2012 |
$-1 |
| 2011 |
$1 |
Evoke Pharma Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$4 |
| 2024-06-30 |
$3 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$-1 |
| 2023-06-30 |
$1 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$6 |
| 2022-06-30 |
$7 |
| 2022-03-31 |
$2 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$8 |
| 2020-12-31 |
$-3 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-0 |
| 2020-03-31 |
$3 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$5 |
| 2019-06-30 |
$6 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$4 |
| 2018-09-30 |
$5 |
| 2018-06-30 |
$5 |
| 2018-03-31 |
$4 |
| 2017-12-31 |
$2 |
| 2017-09-30 |
$2 |
| 2017-06-30 |
$7 |
| 2017-03-31 |
$8 |
| 2016-12-31 |
$4 |
| 2016-09-30 |
$5 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$1 |
| 2015-12-31 |
$3 |
| 2015-09-30 |
$5 |
| 2015-06-30 |
$4 |
| 2015-03-31 |
$6 |
| 2014-12-31 |
$9 |
| 2014-09-30 |
$12 |
| 2014-06-30 |
$15 |
| 2014-03-31 |
$18 |
| 2013-12-31 |
$21 |
| 2013-09-30 |
$19 |
| 2013-06-30 |
$-2 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
|
| 2012-09-30 |
$0 |
| 2012-06-30 |
$0 |
| 2011-12-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
